DRAM vs SMHX: Which Is the Better Pick in 2026?

Overview

DRAM and SMHX are both technology-focused ETFs, but they target different segments of the semiconductor value chain. DRAM invests in memory chip manufacturers and tracks companies whose primary business is DRAM, NAND flash, and related memory products. SMHX tracks fabless semiconductor companies—firms that design chips but outsource manufacturing. The key distinction is that DRAM owns memory-specific equity exposure, while SMHX owns design-stage chip companies with no manufacturing footprint.

How they differ

The biggest difference is their underlying strategy: DRAM focuses on memory production (a capital-intensive, commoditized segment), while SMHX tracks fabless design firms that operate asset-light business models. SMHX tracks an index and charges a lower expense ratio of 0.35% versus DRAM's 0.65%; SMHX also pays a minimal 0.02% distribution yield annually, while DRAM pays no distributions. DRAM has substantially larger assets under management at $23.9B compared to SMHX's $267M, reflecting the maturity difference between a fund launched in April 2026 and SMHX's August 2024 inception. SMHX carries a beta of 2.2504, indicating higher market sensitivity than DRAM's reported beta of 0.0, though DRAM's zero beta reading warrants scrutiny given it holds volatile memory equities.

Who each is best for

• DRAM: Fits investors seeking pure-play exposure to the memory chip manufacturing cycle, with conviction that memory demand—driven by AI infrastructure buildout and data center expansion—will sustain valuations in this capital-intensive, cyclical sector.

• SMHX: Designed for investors who prefer asset-light semiconductor exposure through fabless design firms and want to track an index-based strategy; suitable for those building a diversified technology portfolio where index discipline and lower fees appeal more than sector concentration.

Key risks to know

• Memory commodity risk: DRAM holders face cyclical earnings volatility tied to chip pricing and supply-demand swings; memory markets have historically shown sharp price compression during oversupply periods, which can pressure stock valuations regardless of AI tailwinds.

• Index tracking divergence: SMHX's fabless index exposure means performance depends on which design-stage companies the index includes; concentration in a few large fabless leaders (such as Nvidia or AMD-adjacent firms) could make index tracking tighter or looser than intended depending on index methodology updates.

• Beta reporting uncertainty: DRAM's zero beta conflicts with the volatility profile typical of memory equities, suggesting either a reporting lag, calculation methodology issue, or that the fund's holdings have recently shifted; investors should independently verify recent holdings alignment with stated strategy.

• Liquidity and AUM risk: SMHX's $267M in assets is substantially smaller than DRAM's $23.9B, which can create tighter bid-ask spreads and lower trading volume; newer inception dates for both funds mean less real-world stress-test data during market downturns.

• Sector concentration: Both funds concentrate in semiconductor subsectors prone to cyclical underperformance; DRAM's memory focus and SMHX's fabless focus mean little diversification across the broader economy if chip-sector valuations compress.

Bottom line

If you're betting specifically on memory-chip demand from AI infrastructure, DRAM offers direct exposure; if you prefer index-based discipline, lower fees, and asset-light design-stage companies, SMHX's lower expense ratio and index tracking provide a different entry point to semiconductor upside. Both funds are concentrated semiconductor plays with minimal diversification, and DRAM's zero beta reading deserves independent verification before assuming it offers lower volatility than traditional memory equity. Past performance does not predict future results.